Encellin is a 2016 Rosenman Innovator and Founders Pledge company.
Early-stage health tech companies chosen for their innovative technology and high growth potential.
The proprietary DotEndo test combines information from a set of new disease biomarkers with machine learning algorithms.
The company was awarded over $3.6 million by the U.S. Army Medical Research and Material Command.
Enspectra met the lead investor for its recent Series A round last year in the Rosenman Innovators program.
The company’s technology is a minimally invasive approach toward treating anal fistula.
The competition was hosted by the UCSF-Stanford Pediatric Device Consortium.
The two companies will develop inhaled nitric oxide technology to treat pulmonary arterial hypertension.
CureMetrix cmTriage is a workflow optimization tool that enables a radiologist to customize, sort, and prioritize their mammography worklist.
Luma’s Illuvinate system is an in-home treatment for psoriasis.
GammaTile™ Therapy is an FDA-cleared, surgically targeted radiation therapy for patients with recurrent brain tumors.
The FDA-cleared treatment is based on proven techniques and designed for lasting remission.
The funds will accelerate development and enable Cenofex to complete early clinical trials.
Catalia is developing Mabu, a personal health assistant robot.
Green Sun’s dynamic brace applies continuous corrective pressure to the spine of adolescent patients with scoliosis.
Funds from the Employment Achievement Award from the Triumph Foundation will offset clinical trial costs.
The company has developed a better fetal monitor to improve outcomes for mothers and babies during childbirth.
The new standard of care will reduce anxiety and risks for hospitalized patients.
Patients undergoing surgery for recurrent brain tumors will benefit from GT Medical's GammaTile™ Therapy, which helps prevent additional tumor recurrence.
Perceptive is developing minimally-invasive, needle-guided solutions for safe and cost-effective interventional procedures in the areas of cardiology, interventional radiology, interventional oncology and emergency medicine.
Zeto's "dry electrode" headset, the first of its kind to obtain FDA approval, enables doctors to obtain EEGs quickly and conveniently to 10-20 EEG specifications.
The extra funding gives the company a longer runway to develop its AI software for radiation therapy.
Siren recently unveiled its first product and announced a $3.4M funding round that will help them commercialize other products.
Zenflow’s solution is a device to prop open the urethra, thereby mitigating the symptoms of BPH without the need for surgery or medications.
The Menlo Park-based startup is developing implantable technology for integrated remote patient monitoring, together with a cloud solution.
Arterys unveiled the MICA platform in Chicago at the Radiological Society of North America annual meeting.
Arterys will expand its web-based AI platform, launch several products, and accelerate its cardiac offering.
Catalia can roll out their platform to patients and expand their AI platform into new disease states.